![Andy Billinton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andy Billinton
Director Técnico/Científico/I+D en Transine Therapeutics Ltd. .
Cargos activos de Andy Billinton
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Transine Therapeutics Ltd.
![]() Transine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021. | Director Técnico/Científico/I+D | 23/06/2022 | - |
Historial de carrera de Andy Billinton
Antiguos cargos conocidos de Andy Billinton.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
NodThera Ltd.
![]() NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Corporate Officer/Principal | - | - |
Formación de Andy Billinton.
University of Birmingham | Doctorate Degree |
Estadísticas
Internacional
Reino Unido | 4 |
Operativa
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Transine Therapeutics Ltd.
![]() Transine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021. | Health Technology |
NodThera Ltd.
![]() NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Andy Billinton
- Experiencia